Pharmacodynamic activity of the AKT inhibitor AZD5363 in patients with advanced solid tumors.
Paul Elvin
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Amy Palmer
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Research Funding - AstraZeneca
Chris Womack
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Matthew Tall
No relevant relationships to disclose
Karen E Swales
No relevant relationships to disclose
Michelle D Garrett
No relevant relationships to disclose
Udai Banerji
Employment or Leadership Position - The Institute of Cancer Research
Kenji Tamura
No relevant relationships to disclose
S Y Amy Cheung
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Peter Lawrence
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Justin Lindemann
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Helen Ambrose
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Christine Stephens
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Barry Davies
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Andrew Foxley
Employment or Leadership Position - AstraZeneca
Martin Pass
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Elizabeth A. Harrington
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
J. Carl Barrett
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca